Manufacture of homogenised food preparations and dietetic food
BIOPHARMA AS
Revenue 2024
NOK 28.3m
Operating profit
NOK 5.6m
Equity
NOK 5.9m
Incorporated
2000
Employees
8
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 28.3m | |
| Total operating costs | 22.6m | |
| Operating profit (EBIT) | 5.6m | |
| Net financial items | 490k | |
| Profit for the year | 4.8m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 18.0m | |
| of which current assets | 18.0m | |
| Equity | 5.9m | |
| Total liabilities | 12.2m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.